Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$2.39 USD
+0.06 (2.58%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.38 -0.01 (-0.42%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/1/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | -11.11% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.70 |
Next Year | -0.57 |
EPS (TTM) | -0.83 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.64M | 10.45M | 30.99M | 104.15M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 6.36M | 17.06M | 46.80M | 171.90M |
Low Estimate | 1.80M | 3.50M | 14.00M | 52.10M |
Year ago Sales | 0.32M | 0.16M | 1.21M | 30.99M |
Year over Year Growth Est. | 1,038.13% | 6,429.38% | 2,471.37% | 236.12% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.17 | -0.70 | -0.57 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.18 | -0.15 | -0.65 | -0.21 |
High Estimate | -0.14 | -0.15 | -0.62 | -0.21 |
Low Estimate | -0.21 | -0.21 | -0.83 | -0.75 |
Year ago EPS | -0.22 | -0.21 | -0.79 | -0.70 |
Year over Year Growth Est. | 18.18% | 19.05% | 11.39% | 19.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.17 | -0.70 | -0.57 |
7 Days Ago | -0.18 | -0.17 | -0.70 | -0.57 |
30 Days Ago | -0.18 | -0.17 | -0.70 | -0.57 |
60 Days Ago | -0.18 | -0.17 | -0.72 | -0.68 |
90 Days Ago | -0.18 | -0.17 | -0.71 | -0.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.17 | -0.70 | -0.57 |
Zacks Consensus Estimate | -0.18 | -0.17 | -0.70 | -0.57 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.20 | -0.21 | -0.22 | NA |
Estimate | -0.18 | -0.23 | -0.22 | -0.17 | NA |
Difference | -0.02 | 0.03 | 0.01 | -0.05 | -0.01 |
Surprise | -11.11% | 13.04% | 4.55% | -29.41% | -5.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more